Acute graft-versus-host disease (GVHD) in the gut is common following hematopoetic cell transplantation (HCT) and is associated with high mortality. However, it remains unclear whether Th1 or Th17 CD4 + T cells can initiate acute gut GVHD. In this issue of the JCI, Ullrich and colleagues identified a subset of CD4 + T cells that express high levels of IL-7Ra and granulocyte-macrophage CSF (IL-7Ra hi GM-CSF + ) cells that are involved in the induction of acute gut GVHD in murine models. The IL-7Ra hi GM-CSF + effector memory cells were BATF dependent, RORgt independent, produced large amounts of GM-CSF and IFN-g, and released little IL-17. CD4 + IL-7Ra hi GM-CSF + cells were not classical Th17 cells but had more of a Th1-like phenotype, despite their dependence on BATF. This work suggests that targeting the IL-7R/BATF/GM-CSF axis has therapeutic potential for treating acute gut GVHD.
Organ and stage specificity of GVHD-mediating T cells
Graft-versus-host disease (GVHD) is an exaggerated systemic immune response initiated by alloreactive T cells that primarily target the gut, liver, lung, and skin (1) . The progression of GVHD can be divided into acute and chronic phases. While acute GVHD is characterized by T cell infiltration and tissue cell apoptosis (2) , chronic GVHD is often a continuation of acute GVHD that is perpetuated by graft-derived memory T cells along with de novo thymus-generated T cells and characterized by subsiding T cell infiltration and increasing collagen production (3, 4) .
When activated, naive CD4 + T cells can differentiate into Th1, Th2, or Th17 or Tregs cells, depending on the cytokine milieu, and are controlled by specific transcription factors . Th1 differentiation is controlled by the transcription factors T-bet and STAT1/ STAT4; Th2 by Gata3 and STAT6; Th17 by RORγt and Stat3/BATF; and Treg cells by FOXP3 and STAT5 (5-7). After hematopoietic cell transplantation (HCT), alloreactive T cells also differentiate into Th1, Th2, or Th17 or Treg cells and reciprocally regulate each other (8) . For example, IFN-γ from Th1 cells can suppress Th2 and Th17 cell differentiation, and IL-17 from Th17 cells can inhibit Th1 cell differentiation (8, 9) . The organ-specific tissue damage mediated by subsets of Th cells is associated with tissue-specific tropism that is mediated by differential expression of homing and chemokine receptors (8) . For example, Th1 cells express high levels of integrin α4β7 and the chemokine receptors CCR9 and CXCR3, while gut tissue expresses the α4β7 ligand MAdCAM-1, the CCR9 ligand CCL25, and the CXCR3 ligand CCL9-11 (8) . Early after HCT, the acute inflammatory environment caused by the conditioning regimen favors differentiation of Th1 cells and cytotoxic T lymphocytes (Tc1), the predominant infiltrating T cells in the gut (8, 10) . Th17 cells express CCR4 and CCR6, and lung and skin tissues express the CCR4 ligands CCL17 and CCL22, as well as the CCR6 ligand CCL20 (8) . Thus, Th2 and Th17 cells preferentially infiltrate lung and skin tissues (8) . Skin-infiltrating T cells are observed mostly as Th1 cells early after HCT, while Th17 cell infiltration occurs gradually and becomes obvious during chronic GVHD (11) . Th17 cells mediate cutaneous chronic GVHD via IL-22 production (12); therefore, tissue infiltration of Th subsets is target-organ specific and inflammation-phase dependent. Gut tissue-infiltrating Th cells during the early acute phase of GVHD are predominantly IFN-γ-producing Th1 and Tc1 cells.
IFN-γ-but not IL-17-producing CD4 + T cells ignite acute gut GVHD Alloreactive T cell activation has been proposed to begin in the mesenteric lymph nodes (MLNs) and Peyer's patches (13, 14) . Acute GVHD in the gut, the most common site of acute GVHD, results in a high mortality rate (15) Acute graft-versus-host disease (GVHD) in the gut is common following hematopoetic cell transplantation (HCT) and is associated with high mortality. However, it remains unclear whether Th1 or Th17 CD4 + T cells can initiate acute gut GVHD. In this issue of the JCI, Ullrich While depletion of naive T cells reduces chronic GVHD in both mouse models and humans, memory T cells are still able to induce acute gut GVHD (25) . Therefore, it is possible that a subset of memory CD4 + T cells can initiate gut GVHD, followed by amplification of the disease by activation and expansion of naive alloreactive T cells. Here, we propose a hypothesis that the memory CD4 + T cells ignite and promote acute gut GVHD development that regulate the differential generation of BATF-dependent, RORγt-independent CD4 + Tem cells in acute gut GVHD as compared with BATF-dependent, RORγt-dependent Th17 cells in autoimmune EAE and colitis remain unclear, and these differences are likely conferred by the specific cytokine environment encountered. Acute GVHD is characterized by a cytokine storm with high concentrations of IFN-γ, TNF-α, IL-1, and IL-6 and low levels of TGF-β, a cytokine environment that favors Th1, but not Th17, differentiation (10) . Moreover, IFN-γ from Th1 cells can further inhibit this Th17 differentiation (8) . As acute inflammation subsides and transitions into chronic inflammation, concentrations of IFN-γ decrease, those of TGF-β increase, and the cytokine environment gradually begins to favor Th17 differentiation (10) . Thus, Th17 may participate in the pathogenesis at the early chronic GVHD phase. Although studies indicate that Th17 cells contribute to the pathogenesis of acute GVHD in mouse models and in humans (21, 22) , kinetic analysis of gut tissue-infiltrating Th1 and Th17 cells has not been reported. Additionally, transplants from mice lacking RORγt (Rorγt Acute gut GVHD pathogenesis differs from chronic GVHD and autoimmune colitis BATF was found to be required for the differentiation of RORγt-dependent Th17 cells that produced IL-17 and GM-CSF in a mouse model of experimental autoimmune encephalomyelitis (EAE), as well as in colitis-associated colon cancer (6, 20) ; however, the BATF-dependent IL-7Rα hi GM-CSF + CD4 + Tem cells in acute GVHD gut tissue were RORγt independent and did not produce IL-17, but instead produced IFN-γ, which is usually produced by T-betdependent Th1 cells (17) . The mechanisms (8, 10) . However, as acute inflammation transitions into the chronic phase, and as tissue concentrations of IFN-γ decrease and those of TGF-β increase, the effect of TGF-β, along with IL-6 and IL-1, leads to Th17 cell differentiation. Therefore, BATF-dependent, RORγt-independent Th1-like CD4 + T cells initiate acute gut GVHD development, and RORt-dependent Th17 cells may participate in the early stage of chronic GVHD.
Future studies are warranted to test this hypothesis. In particular, several questions need to be answered. First, can CD11c 
